Skip to main content

Table 1 Demographic and clinical characteristics of HIV-1-infected patients

From: Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration

Characteristic   Absolute value  
Number of participants   61  
Number of male participants, (%)   56 (92%)
Age (y), median [IQR]   43 [35-48]
Route of transmission, (%)    
  homosexual 46 (76%)
  heterosexual 13 (21%)
  blood products 2 (3%)
Nationality, (%)    
  Japanese 61 (100%)
Nadir CD4 cell count (/μl), median [IQR]*   175 [54-256]
Pre-ART VL (copies/ml), median [IQR]*   85500 [41500-322500]
Current CD4 cell count (/μl), median [IQR]   569 [442-818]
Current ART regimen, no. (%)    
  PI-based 32 (52%)
  NNRTI-based 25 (41%)
  3-NRTI 4 (7%)
Duration of VL suppression (days), median [IQR]   2205 [784-2737]
  1. * Data are unavailable for seven (11%) patients. IQR, interquartile range; VL, viral load; ART, antiretroviral therapy; PI, protease inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor.